It is important that the medical profession play a significant role in critically evaluating the
use of diagnostic procedures and therapies as they are introduced and tested in the …

Chronic kidney disease1 (CKD) is a worldwide public health problem. In the United States,
there is a rising incidence and prevalence of kidney failure, with poor outcomes and high …

The recommendations listed in this CPG are, whenever possible, evidence based. An
extensive evidence review was conducted through October 2012, and other selected …

1.1. Methodology and Evidence Review The recommendations listed in this document are,
whenever possible, evidence based. The current document constitutes a full revision and …

The recommendations listed in this CPG are, whenever possible, evidence based. An
extensive evidence review was conducted through October 2012, and other selected …

Cardiovascular morbidity and mortality in patients with chronic kidney disease (CKD) is high,
and the presence of CKD worsens outcomes of cardiovascular disease (CVD). CKD is …

Background End-stage renal disease substantially increases the risks of death,
cardiovascular disease, and use of specialized health care, but the effects of less severe …

The standing guideline writing committee along with the parent Task Force identified trials
and other key data through October 2011 that may impact guideline recommendations. On …

Current guidelines identify people with chronic kidney disease (CKD) as being at high risk
for cardiovascular and all-cause mortality. Because as many as 19 million Americans may …

Background Transplantation of nonrenal organs is often complicated by chronic renal
disease with multifactorial causes. We conducted a population-based cohort analysis to …